DiaMedica Therapeutics, Inc. (DMAC)
8.48
+0.17
(+2.05%)
USD |
NASDAQ |
Dec 19, 16:00
8.49
+0.01
(+0.12%)
After-Hours: 20:00
DiaMedica Therapeutics EPS Diluted (Quarterly): -0.1737 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| XOMA Royalty Corp. | 0.6991 |
| Avantor, Inc. | -1.044 |
| NovaBay Pharmaceuticals, Inc. | -0.22 |
| Palatin Technologies, Inc. | 4.258 |
| Theriva Biologics, Inc. | -0.4507 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -8.62M |
| Total Expenses (Quarterly) | 8.62M |
| Enterprise Value | 386.56M |
| Earnings Yield | -8.46% |
| Normalized Earnings Yield | -8.459 |